News
A strain of the virus that causes the common cold has been found to potentially target, infect and kill cancer cells, according to researchers from...
The FDA has made the controversial decision to approve the nuclear export inhibitor Xpovio from Karyopharm Therapeutics, in combination with...
Cancer deaths cost the US economy $94.4 billion in lifetime earnings in 2015, according to figures from the American Cancer Society.
There have been price hikes on more than 3,400 drugs in the United States in the first six months of 2019, according to analysis by Rx Savings...
Alexion has received marketing authorisation from the European Commission for its long-acting C5 complement inhibitor Ultomiris (ravulizumab) in...
The British government has called for more research into cannabis-based medicinal products (CBMPs).
ViiV Healthcare, the specialist HIV firm majority owned by GSK, is celebrating the news that the European Commission has chosen to approve Dovato (...
American scientists have been able to combine a new form of antiretroviral therapy (ART) with gene editing tool CRISPR/Cas9 to cure mice with HIV.
Roche has unveiled new Phase 3 data indicating that Xofluza was well-tolerated and of comparable efficacy to its other therapy Tamiflu in the...
The Department of Health and Human Services (HHS) has been awarded a new patent on drugs that prevent HIV.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
